IPG Photonics Q3 Revenue Rises 15% as Margins Improve

IPG Photonics Corporation (Nasdaq: IPGP) reported a 15% year-over-year increase in third-quarter revenue, extending its run of double-digit growth to four consecutive quarters as stronger welding, additive manufacturing, defense and semiconductor sales supported results. Lower product costs and $5 million of net tariff refunds also lifted gross margin, while adjusted earnings and EBITDA increased sharply from a year earlier.

Revenue reached $287.5 million for the quarter ended September 30, 2026, up from $250.8 million a year earlier and 3% from $278.6 million in the second quarter. GAAP gross margin rose 120 basis points year over year and 30 basis points sequentially to 40.7%. Adjusted gross margin increased by the same amounts to 41.0%.

GAAP operating income rose to $20.8 million from $7.9 million a year earlier, while adjusted operating income more than doubled to $26.5 million. Net income increased 171% to $20.3 million, and diluted earnings per share advanced to $0.47 from $0.18.

On a non-GAAP basis, adjusted net income climbed 78% to $26.3 million, with adjusted EPS rising 74% to $0.61. Adjusted EBITDA increased 39% to $51.5 million.

Industrial and Advanced Solutions both expand

Industrial Solutions revenue increased 12% year over year to $239.5 million and was 1% higher sequentially. Welding and additive manufacturing drove the annual increase, while cutting, welding and additive manufacturing supported growth from the second quarter.

Advanced Solutions revenue rose 33% from a year earlier and 15% sequentially to $48.0 million. IPG attributed both comparisons to higher defense and semiconductor sales tied to its strategic initiatives.

North American revenue increased to approximately $83 million from $62 million a year earlier and $72 million in the second quarter. Welding and defense drove the year-over-year gain, while defense, medical, cleaning, cutting and additive manufacturing contributed to sequential growth.

European sales were approximately $62 million, slightly below the prior-year period but above $59 million in the second quarter, supported sequentially by cutting, welding and semiconductor applications. Asian revenue was about $139 million, up from $122 million a year earlier and flat sequentially, with higher welding revenue driving the annual increase.

Adjusted operating expenses totaled $91.2 million, up 4% year over year and 2% sequentially. The company said the annual increase primarily reflected continued investment in growth opportunities. The second-quarter comparison was affected by a $1.8 million German research and development tax credit recorded in that period.

Cash position remains debt-free

IPG ended the quarter with $926 million in cash and short-term investments and no total debt. Third-quarter cash from operations was $46 million, while capital expenditures totaled $17 million and stock repurchases were $3 million.

For the first nine months of 2026, cash from operations was $79 million and capital expenditures were $54 million, resulting in free cash flow of $25 million. That compared with negative free cash flow of $14 million in the corresponding 2025 period.

Fourth-quarter outlook accounts for tariffs without refunds

For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million and adjusted gross margin of 37.0% to 40.0%. Adjusted operating expenses are projected at $91 million to $94 million.

The company forecast adjusted EPS of $0.30 to $0.60 and adjusted EBITDA of $33 million to $50 million. Its outlook assumes a tax rate of approximately 25% and roughly 43 million diluted shares.

Management based the outlook on a generally stable operating environment and excluded any contribution from the acquisition of Lumibird Medical. The gross-margin forecast includes IPG’s current tariff estimate and assumes no tariff refunds, in contrast with the $5 million net refund benefit recorded in the third quarter. Third-quarter book-to-bill was approximately 1.

IPG identified foreign-exchange movements, tariff and trade-policy changes, demand conditions across its industries and geographic markets, pricing pressure, manufacturing capacity and the fixed-cost structure associated with vertical integration among the factors that could cause actual results to differ from its outlook. The company also plans to present its strategy and long-term financial targets at an investor day scheduled for March 2, 2027.